L-carnitine infusion does not alleviate lipid-induced insulin resistance and metabolic inflexibility von Bruls, Yvonne M. H, op den Kamp, Yvo J. M, Phielix, Esther, Lindeboom, Lucas, Havekes, Bas, Schaart, Gert, Moonen-Kornips, Esther, Wildberger, Joachim E, Hesselink, Matthijs K. C, Schrauwen, Patrick, Schrauwen-Hinderling, Vera B

Volltext

Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial von Op den Kamp, Yvo J M, de Ligt, Marlies, Dautzenberg, Bas, Kornips, Esther, Esterline, Russell, Hesselink, Matthijs K C, Hoeks, Joris, Schrauwen-Hinderling, Vera B, Havekes, Bas, Oscarsson, Jan, Phielix, Esther, Schrauwen, Patrick

Volltext

Erratum. Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care 2021;44:1334-... von Kamp, Yvo J M Op den, de Ligt, Marlies, Dautzenberg, Bas, Kornips, Esther, Esterline, Russell, Hesselink, Matthijs K C, Hoeks, Joris, Schrauwen-Hinderling, Vera B, Havekes, Bas, Oscarsson, Jan, Phielix, Esther, Schrauwen, Patrick

Volltext

Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism von op den Kamp, Yvo J.M., Gemmink, Anne, de Ligt, Marlies, Dautzenberg, Bas, Kornips, Esther, Jorgensen, Johanna A., Schaart, Gert, Esterline, Russell, Pava, Diego A., Hoeks, Joris, Schrauwen-Hinderling, Vera B., Kersten, Sander, Havekes, Bas, Koves, Timothy R., Muoio, Deborah M., Hesselink, Matthijs K.C., Oscarsson, Jan, Phielix, Esther, Schrauwen, Patrick

Volltext